Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.18 USD
+0.01 (7.25%)
Updated May 3, 2024 04:00 PM ET
After-Market: $0.18 0.00 (-1.91%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.52 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | 44.87% |
ABR | 1.00 |
Earnings ESP
|
40.00% |
---|---|
Current Year | -3.18 |
Next Year | -1.15 |
EPS (TTM) | -8.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.00M | 4.05M | 16.60M | 18.70M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 4.30M | 4.30M | 18.10M | 21.40M |
Low Estimate | 3.70M | 3.80M | 15.10M | 16.00M |
Year ago Sales | 0.00M | 0.00M | 7.77M | 16.60M |
Year over Year Growth Est. | NA | NA | 113.70% | 12.65% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.52 | -0.92 | -3.18 | -1.15 |
# of Estimates | 3 | 3 | 3 | 2 |
Most Recent Consensus | -0.31 | -0.29 | -1.11 | -0.70 |
High Estimate | -0.14 | -0.29 | -1.11 | -0.70 |
Low Estimate | -1.10 | -1.42 | -5.83 | -1.60 |
Year ago EPS | -3.25 | -2.68 | -6.85 | -3.18 |
Year over Year Growth Est. | 84.00% | 65.67% | 53.58% | 63.84% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.52 | -0.92 | -3.18 | -1.15 |
7 Days Ago | -0.62 | -1.24 | -3.71 | -1.76 |
30 Days Ago | -0.62 | -1.24 | -3.71 | -1.76 |
60 Days Ago | -0.62 | -1.24 | -3.01 | -1.34 |
90 Days Ago | -0.62 | -1.24 | -3.71 | -1.76 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.29 | -1.11 | -0.70 |
Zacks Consensus Estimate | -0.52 | -0.92 | -3.18 | -1.15 |
Earnings ESP | 40.00% | 68.48% | 65.09% | 39.13% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -1.83 | -2.68 | -3.25 | NA |
Estimate | -1.56 | -1.49 | -2.78 | -2.50 | NA |
Difference | 0.70 | -0.34 | 0.10 | -0.75 | -0.07 |
Surprise | 44.87% | -22.82% | 3.60% | -30.00% | -1.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more